Pacer Advisors’s Assembly Biosciences ASMB Stock Holding History

Pacer Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-69	Closed	-$14K	–	1506
2020 Q3	$14K	Buy	+69	New	+$17.4K	﹤0.01%	1368

Other funds holding ASMB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Pacer Advisors's ASMB Position: Q4 2020 in Review

Pacer Advisors sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 69 shares — an estimated $14K sold.

Pacer Advisors first reported a position in ASMB in Q3 2020 and held it in 1 quarter. The position peaked at $14K in Q3 2020. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

Pacer Advisors reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
Pacer Advisors sold 69 Assembly Biosciences shares in Q4 2020, an estimated $14K.
Pacer Advisors first reported a position in Assembly Biosciences in Q3 2020 and held it in 1 quarter.
Pacer Advisors's Assembly Biosciences position peaked at $14K in Q3 2020.
109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Pacer Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.